Indian pharma grows at 9.5% CAGR in last five years

Indian pharma grows at 9.5% CAGR in last five years

Indian pharma grows at 9.5% CAGR in last five years

BusinessToday.In
  • Dec 23, 2020,
  • Updated Dec 23, 2020 9:37 AM IST
Advertisement
  • 1/5
India is among top 10 nations in pharma spending globally. In value terms, it is one of the top 3 and growing at a fast pace due to its population size, increasing chronic diseases, and rising healthcare facilities.
SHIVANI SHARMA, PRAGATI SRIVASTAVA
  • 2/5
Indian pharma has grown at 9.5% CAGR over the past five years despite multiple challenges such as policy changes, demonetisation and GST rollout.
  • 3/5
Indian pharma has been consistently growing in double digits in recent years.
  • 4/5
Cardiac, Diabetes, Derma, CNS and Vitamins have been the fastest growing over the past four years, while anti-infectives the slowest (6.5% CAGR).
  • 5/5
Top 20 companies include four MNCs. They are Abbott India, GSK, Sanofi and Pfizer.
Advertisement